NEW YORK ( TheStreet) -- CHANGE IN RATINGS Advanced Micro ( AMD) downgraded at Citigroup from Buy to Neutral, Citigroup said. Estimates also cut, following negative checks in Asia. Abercrombie & Fitch ( ANF) rated new Sell at Citigroup. $32 price target. Company's fashion trends are lagging. Cliffs Natural ( CLF) upgraded at Nomura to Buy, Nomura said. $54 price target. Iron ore prices may be at an inflection point. Darden ( DRI) downgraded at Baird from Outperform to Neutral, Robert Baird said. $58 price target. Valuation call, as the stock is up 23% year-to-date. Cabot Microelectronics ( CCMP) upgraded to buy at TheStreet Ratings. Electronics for Imaging ( EFII) upgraded to buy at TheStreet Ratings. Foster Wheeler ( FWLT) upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $30 price target. Seeing a cyclical recovery in the overall E&C market. Haemonetics ( HAE) rated new Buy at Benchmark. $89 price target. Company can leverage its steady organic revenue growth. Intel ( INTC) downgraded at Citigroup from Buy to Neutral, Citigroup said. Company cut guidance and the PC market will likely remain soft. Limited ( LTD) rated new Buy at Citigroup. $60 price target. Company is managing inventory well and growing in non-apparel categories. Magnum Hunter ( MHR) rated new Outperform at Credit Suisse. $6 price target. Company can deliver solid growth through 2014. Marvell Technology ( MRVL) downgraded at Citigroup from Buy to Neutral, Citigroup said. Chip sector lacks near-term catalysts. Nike ( NKE) downgraded at Citigroup from Buy to Neutral, Citigroup said. Valuation call, based on a $101 price target. Northrop Grumman ( NOC) downgraded at UBS from Neutral to Sell, UBS said. Valuation call, based on a $64 price target. AT&T ( T) downgraded at Hudson Square from Buy to Hold, Hudson Square said. Valuation call, as marginal will be difficult to find from current levels. TJX ( TJX) rated new Buy at Citigroup. $55 price target. Company can continue to expand its operating margin. T. Rowe Price ( TROW) downgraded at Credit Suisse to Neutral from Outperform, Credit Suisse said. $66 price target. Costs are rising and the company is seeing lower institutional flows.